MNX1 and neoplasm: Ferguson, Gautrey and Strathdee [66] had previously attributed MNX1 activity in haematopoietic cells to epigenetic dysregulation, and suggested that MNX1 could act as both tumour-suppressor and oncogene depending on methylation status.